Original Article
Copyright ©2010 Baishideng.
World J Gastroenterol. May 28, 2010; 16(20): 2484-2495
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2484
Table 1 Details of patients’ data
Case No.SexAge (yr)Type of diseaseAnal lesion
Disease durationPrevious segmental resectionInitial onset or relapseHospitalization
FistulaTagOn admission
Main medicationDuration of SVD (d)On discharge
CDAICRP (mg/dL)CDAICRP (mg/dL)Morphology
1F52C--< 1 mo-I1610.6Sulfasalazine58250.9Active (CS)
2M22C++4 yr and 3 mo+R2643.1Infliximab55620NT
3F21EC+-5 yr and 8 mo-R1336.3Infliximab48380NT
4M22EC+-5 yr and 3 mo-R6795.9Infliximab82720.1Remission (CS)
5M23EC+-< 2 mo-I2351.5Infliximab55980.1Near remission (CS)
6M28C--2 mo-I882.5Infliximab68590.5Near remission (CS)
7F77C--1 yr and 10 mo-R23313.8Infliximab49390Remission (CS and BE)
8M30C+-6 mo-I2814.6Infliximab50390.1Remission (CS)
9M55C++8 mo-I1721.0Infliximab46670.5Remission (CS and BE)
10M19EC+-4 mo-I1470.8Infliximab43400Remission (CS and BE)
11F21EC-+3 mo-I3356.0Infliximab49470.3Improved still active (CS and BE)
12F50E--1 mo-I4885.1Infliximab43530Remission (CS)
13M28C--3 mo-I520.6Infliximab5020Remission (CS)
14M19EC++2 yr and 1 mo-I1930.8Infliximab43350Near remission (CS and BE)
15M29C+-1 yr and 4 mo-I1260.2Infliximab4380Improved still active (CS)
16M30C+-1 yr and 1 mo-I21111.8Infliximab47280.8Near remission (CS and BE)
17F21EC-+6 yr and 2 mo-R5443.7Infliximab46640.3Improved still active (BE)
18F45EC--13 yr+R, PO 21st d1430.2Metronidazole191050.1NT
19M21EC++2 yr-I, PO 13th d2171.1Metronidazole181660.1NT
20M34EC--17 yr-R, PO 12th d1460Metronidazole241080.1NT
21M25C-+13 yr-R, PO 17th d3727.1Metronidazole211490NT
22F23EC--8 yr-R, PO 25th d1518.0Metronidazole831410.8NT
Table 2 Nutritional data and hemoglobin during hospitalization
Case No.Dietary pattern beforehospitalizationHospitalization
On admission
On discharge
BMI (kg/m2)Albmin(g/dL)Chol(mg/dL)ChE(IU/mL)Hemoglobin(g/dL)BMI (kg/m2)Albmin(g/dL)Chol(mg/dL)ChE(IU/mL)Hemoglobin(g/dL)
1Pro-Japanese21.14.7155492914.820.54.1145495913.0
2Standard17.23.8140405914.017.14.5145417015.5
3Japanese17.23.710220038.319.24.0152411711.1
4Pro-Japanese18.52.81007898.617.93.0116187612.7
5Pro-western17.74.8132559215.817.04.2135505714.4
6Pro-western21.33.0122287610.820.74.4192432110.8
7Pro-Japanese17.22.19515497.516.83.2177263311.6
8Pro-western19.23.2128344112.618.34.2114491114.3
9Japanese19.73.9190509413.018.24.1221460214.1
10Pro-western17.64.0147450513.517.64.5154472513.7
11Standard19.83.714740819.518.43.9125483710.3
12Standard24.14.4149515611.021.44.3158662610.7
13Standard24.44.6151459916.222.54.4143437615.1
14Pro-western19.04.7167572215.018.84.4138486116.0
15Pro-western24.14.6188575515.422.44.5137564315.8
16Pro-western22.53.7138375712.321.44.4116430414.3
17Standard18.83.8187270010.618.14.1209279811.8
18Pro-Japanese21.64.1126794310.721.93.9129909810.8
19Pro-western20.14.1150332011.020.14.2152342611.8
20Polymeric diet18.13.9100351211.017.94.1130375713.4
21Standard15.63.5116338710.215.64.0138387011.9
22Pro-Japanese16.53.25823209.916.02.97833559.8
Table 3 Lifestyle and dietary habits
Every day3-5 times/wk1-2 times/wkRareNone
Smoking (No. of cigarettes/d)20 ≤6-191-5RareP
Regular exerciseRRRP
AlcoholP
Eating between mealsPRR
Type of diet (D)Semi-vegetarian (R)JapanesePro-JapaneseStandard/mixedPro-western (P)
Food
RiceP
Miso soupP
PulsesRP
VegetablesRP
Udon/soba (Japanese noodles)P
Ramen (Chinese noodles)PR
Bread (D)PR
Tea, coffeeCanned coffee (P)R
(Sugar in tea or coffee) (D)Large amount (P)Average amountSmall amountRareNone (R)
JuicePRR
Cola/sodaP
BeefPR
Pork/chicken (D)PR
Minced or processed meatPR
FishP
Cheese/butter/margarinePR
Sweets (D)PRR
Ice cream/milk shakeP
Yoghurt (plain)RP
Green tea (D)RP
Potatoes/starches (D)RP
Fruits (D)RP
Table 4 Content of semi-vegetarian diet (2000 kcal/d)
SVDDRI
Energy
Protein (%)16.1 ± 0.5< 20
Fat (%)18.6 ± 1.420-30
Carbohydrate (%)66.1 ± 1.650-70
Content
Protein (g)80.3 ± 3.0M 60, F 50
Fat (g)41.4 ± 3.6
Carbohydrate (g)330.2 ± 11.4
Dietary fiber (g)32.4 ± 2.1M 20, F 17
Soluble dietary fiber (g)6.8 ± 0.7
Insoluble dietary fiber (g)23.3 ± 1.6
Calcium (mg)873.7 ± 65.2M 600-650, F 600
Phosphorus (mg)1882.7 ± 101.8M 1050, F 900
Iron (mg)19.3 ± 1.3M 7.5, F 10.5
Sodium (mg)4492.9 ± 342.1600
Kalium (mg)4281.7 ± 250.6M 2000, F 1600
Vitamin A (μgRE)1416.6 ± 360.9M 750, F 600
Vitamin B1 (mg)2.0 ± 0.2M 1.4, F 1.1
Vitamin B2 (mg)1.3 ± 0.2M 1.6, F 1.2
Niacin (mg)26.6 ± 3.1M 15, F 12
Vitamin C (mg)133.1 ± 23.4100
Vitamin D (μg)3.2 ± 1.05
Vitamin E (mg)12.3 ± 1.9M 9, F 8
Cholesterol (mg)285.9 ± 72.1M < 700, F < 600
NaCl (g)10.9 ± 0.8M < 10, F < 8
Polyunsaturated fatty acid (g)13.9 ± 1.9
Monounsaturated fatty acid (g)9.3 ± 0.9
Saturated fatty acid (g)7.1 ± 0.9
P:S ratio2.0 ± 0.2
Table 5 Follow-up study
Case No.Main medicationDietary pattern
Days of remissionReason for terminationOn final attendance
Month 3Year 1Year 2On relapseCDAICRP (mg/dL)BMI (kg/m2)Alb (g/dL)Chol (mg/dL)ChE (IU/mL)Hemoglobin (g/dL)
1SSZ for 1 yrSVDSVDSVD730Completion00.123.14.5235568414.4
2MesalamineSVDOmniOmni301Relapse1938.217.53.8151326213.8
3MesalamineSVDOmniOmni367Relapse16711.321.13.5133355110.0
4MesalamineSVDSVDSVD730Completion1285.018.72.811411139.3
5SSZ for 1 yrSVDSVD523Moving39019.44.5194550915.0
6MesalamineOmniOmni191Relapse1925.721.73.913430527.9
7NoneSVDSVD442INFX for RA612.019.64.0158506810.9
8MesalamineSVDSVDSVD635Relapse1747.619.13.188267811.3
9MesalamineOmniOmniOmni730Completion480.219.84.3171546115.2
10MesalamineSVDSVDSVD730Completion180.118.25.1181465916.3
11MesalamineSVDSVDSVD730Completion11019.74.7147521513.9
12MesalamineSVDSVDSVD730Completion45020.24.7163626811.3
13MesalamineSVDSVDSVD730Completion0022.84.6171477015.6
14MesalamineSVDSVD666Ongoing270.119.34.7188608415.1
15MesalamineSVDOmni560Ongoing0022.64.8185567116.8
16MesalamineSVDSVD440Ongoing191.921.84.4141514614.2
17MesalamineSVDSVD397Ongoing322.022.53.6216268311.1
18MesalamineSVDSVDSVD730Completion250.422.63.71511022211.1
19MesalamineSVDSVDSVD730Completion62020.14.7139439113.3
20NoneSVDSVDSVD730Completion370.718.24.5156565513.2
21SSZSVDSVDSVD730Completion160.119.04.9205642414.4
22MesalamineSVDOmniOmni630Relapse1185.122.13.584359610.1
Table 6 Maintenance therapy in Crohn's disease following induction of remission or response
Induction therapy
Maintenance therapy
SubjectsRegimenRegimenDuration
1 yr2 yr
Candy et al[55], 1995CDAI > 200PS (diminishing dose) + AZA 12 wkAZA 2.5 mg/kgRemission rate 42% (14/33)
Placebo7% (2/30)
Hanauer et al[56], 2002CDAI ≥ 220Gr (1) and Gr (2)Gr (1) INFX 5 mg/kg every 8 wkRemission rate 25% (28/113)
Responder to a single infusion of infliximabINFX 5 mg/kg at weeks 0, 2, 6Gr (2) INFX 10 mg/kg every 8 wk33% (37/112)
Gr (3) INFX 5 mg/kg then placebo infusion at weeks 2, 6Gr (3) placebo infusion every 8 wk11% (12/110)
Sandborn et al[58], 2005Mild to moderate CDBudesonide 6 mg or 3 mgBudesonide 6 mg or 3 mgRelapse rate 60%-70%
Placebo(In all 3 groups)
Takagi et al[39], 2006Active CDTPN (25 cases), TEN (22 cases),ED (half) + a free diet (half)Relapse rate 26.9% (7/26)
PS (1 case), INFX (3 cases)A free diet64.0% (16/25)
Regueiro et al[59], 2009CD patients who had surgeryIleocolonic resectionINFX 5 mg/kg at weeks 0, 2, 6Remission rate 80% (8/10)
then every 8 wk
Placebo58% (7/13)
Present studyActive CDINFX 5 mg/kg at weeks 0, 2, 6 (16 cases), intestinal resection (5 cases), SSZ (1 case)Semi-vegetarian dietRemission rate 100% (16/16)92%
Omnivorous diet67% (4/6)25%
Table 7 Conventional and current diet in IBD at Nakadori General Hospital
ConventionalCurrent
DietLow-residue dietSemi-lactoovovegetarian diet
MenuCommon for UC and CDSVD for UC (staple: white rice)
SVD for RUC (staple: white rice 70%, brown rice 30%)
SVD for CD (staple: brown rice)
RefrainmentFiber-rich dietMinced or processed meat, bread, fast foods, sweets, cola/soda, juices
Dairy productsRefrainmentEgg, milk: no refrainment
Refrain from cheese/butter/margarine
Calories2000 kcal/dAbout 30 kcal/kg standard body weight/d
Dietary analysisAbsentFood-frequency questionnaire
Dietary guidanceAbsentGuidance by doctor and registered dietitian